ERBB2 and obesity due to melanocortin 4 receptor deficiency: To the best of our knowledge, this is the largest analysis of RCTs examining obesity as a prognostic factor in operable BC patients treated with anthracyclines and taxanes, and adjusting for hormone receptor and HER2 status.